Aesthetic Medical International Holdings Group Limited Announces Openings of Two New Satellite Clinics

Shenzhen, Dec. 30, 2019 (GLOBE NEWSWIRE) -- Aesthetic Medical International Holdings Group Limited (the “Company” or Nasdaq: AIH), a leading provider of aesthetic medical services in China, today announced the openings of two new satellite clinics – Fenghua Pengai Aesthetic Clinic and Deqing Pengai Aesthetic Clinic. The Company invited certain local VIP customers to attend the opening ceremony and marketing sales event on December 28, 2019. The Company holds the majority interest of both new satellite clinics. Fenghua Pengai Aesthetic Clinic is located at Fenghua District, Ningbo City, Zhejiang Province, with floor space of 263 square meters and Deqing Pengai Aesthetic Clinic is located at Deqing County, Huzhou City, Zhejiang Province, with floor space of 130 square meters. Dr. Zhou Pengwu, Chairman and Chief Executive Officer of Aesthetic Medical International Holdings Group Limited, commented, “We are excited to announce the openings of our two new satellite clinics, which can afford us to build upon a combined portfolio and help us further connect with our customers and business partners. Now our hospital network has expanded to 23 hospitals around the world and covered mainland China’s 17 cities, Hong Kong, and Singapore.” About Aesthetic Medical International Holdings Group Limited AIH, known as “Peng’ai” in China, is a leading provider of aesthetic medical services in China. AIH operates through treatment centers that spread across 17 cities in mainland China, and also has presence in Hong Kong and Singapore. Leveraging over 20 years of clinical experience, AIH provides one-stop aesthetic service offerings, including surgical aesthetic treatments, non-surgical aesthetic treatments, and general medical services and other aesthetic services. According to certain third party industry consultant, AIH was the third-largest private aesthetic medical services provider in China in terms of revenue in 2018.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!